{"Tumor-infiltrating": [0], "myeloid": [1, 32], "cells": [2, 33, 52], "(TIMs)": [3], "are": [4], "key": [5], "regulators": [6], "in": [7, 53, 87], "tumor": [8], "progression,": [9], "but": [10], "the": [11, 108, 132], "similarity": [12], "and": [13, 64, 80, 90, 107, 122, 136], "distinction": [14], "of": [15, 30, 46, 73, 110, 119, 131], "their": [16, 85], "fundamental": [17], "properties": [18], "across": [19, 37, 48, 103], "different": [20, 104], "tumors": [21], "remain": [22], "elusive.": [23], "Here,": [24], "by": [25], "performing": [26], "a": [27, 70, 128], "pan-cancer": [28], "analysis": [29], "single": [31], "from": [34], "210": [35], "patients": [36], "15": [38], "human": [39], "cancer": [40, 49, 55, 105], "types,": [41, 106], "we": [42], "identified": [43], "distinct": [44], "features": [45, 118], "TIMs": [47, 111, 135], "types.": [50], "Mast": [51], "nasopharyngeal": [54], "were": [56, 98], "found": [57], "to": [58, 113], "be": [59, 114], "associated": [60, 115], "with": [61, 69, 100, 116], "better": [62], "prognosis": [63], "exhibited": [65], "an": [66], "anti-tumor": [67], "phenotype": [68], "high": [71], "ratio": [72], "TNF+/VEGFA+": [74], "cells.": [75], "Systematic": [76], "comparison": [77], "between": [78], "cDC1-": [79], "cDC2-derived": [81], "LAMP3+": [82], "cDCs": [83], "revealed": [84], "differences": [86], "transcription": [88], "factors": [89], "external": [91], "stimulus.": [92], "Additionally,": [93], "pro-angiogenic": [94], "tumor-associated": [95], "macrophages": [96], "(TAMs)": [97], "characterized": [99], "diverse": [101], "markers": [102], "composition": [109], "appeared": [112], "certain": [117], "somatic": [120], "mutations": [121], "gene": [123], "expressions.": [124], "Our": [125], "results": [126], "provide": [127], "systematic": [129], "view": [130], "highly": [133], "heterogeneous": [134], "suggest": [137], "future": [138], "avenues": [139], "for": [140], "rational,": [141], "targeted": [142], "immunotherapies.": [143]}